A Rare Court Ruling Allowed the Drug Maker Fresenius to Nix a $4.75 Billion Deal. Delaware, Mergers, Acquisitions and Divestitures, Drugs (Pharmaceuticals), Decisions and Verdicts, Fresenius SE & Company KGaA, Akorn Inc